ORCA-3 Phase 3 Trial Reports Statistically Significant Topline Efficacy Results in Smoking Cessation
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/11/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/29/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/29/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/29/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/29/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/29/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/27/22 | 8-K | Current report filing |
|
   |
67 |
| 04/21/22 | DEF 14A | Definitive proxy statements |
|
37 | |
| 04/05/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/16/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |